Welcome to Genevation, where we are committed to revolutionizing cancer treatment through ground breaking innovation and precision. As a pioneering pre-clinical biotechnology company, we focus on creating personalized cancer vaccines and mRNA-based therapeutics tailored to the unique needs of each patient.
Founded in 2022 in London, Genevation was born from a vision to harness cutting-edge science and technology to tackle one of the world's most complex health challenges: Cancer.
About Us
Our Science
At Genevation, science drives our mission to revolutionize cancer therapy and enhance lives. We believe that ground breaking discoveries can lead to transformative treatments, and our approach blends cutting-edge with deep scientific expertise. By harnessing the power of artificial intelligence, we precisely identify tumor-specific neoantigens, setting a new standard in personalized cancer care. With a focus on developing mRNA-based prophylactic and therapeutic vaccines for lung, colon, and skin cancers, we are committed to expanding our pipeline to address a wider array of cancer types.
 |  |  |  |
|---|---|---|---|
 |
Our Cutting-Edge Technology
Genevation leverages advanced platforms, including AI-driven neoantigen discovery and cell-free manufacturing, to innovate at every step of the therapeutic development process. By integrating artificial intelligence with molecular biology, we are at the forefront of precision oncology, creating tailored solutions that promise better outcomes for patients.
Biopsy/Blood Extraction
Studying mutations in cancer cells provides crucial insights into the disease and potential treatment options. By analyzing genetic alterations from patient biopsies, we can develop personalized treatments that specifically target the unique genetic makeup of each patient's cancer.
Mutation Identification
Genevation LTD employs an advanced, AI-driven Neoantigen Identification Platform to accelerate personalized cancer treatment development. By accurately identifying neo-antigens—unique proteins found on cancer cell surfaces—our platform provides critical insights that guide the creation of tailored cancer vaccines. This cutting-edge approach not only enhances research precision but also significantly improves the effectiveness of treatments, offering a transformative solution in the fight against cancer.
mRNA Delivery
Genevation LTD is revolutionizing cancer research with its personalized cancer vaccine pipeline. At the forefront of innovation, we are committed to pioneering new solutions to improve patient outcomes. Currently, we are rigorously evaluating pre-clinical studies targeting lung, skin, and colon cancers as we prepare for the transition to clinical trials, marking a pivotal step toward transformative cancer treatments.
Meet Our Dedicated Team
Comprising bright and like-minded individuals from diverse fields and technical backgrounds, our team at Genevation LTD is united by a shared passion for saving lives. Our collective goal is to provide effective cancer treatment to every individual diagnosed with the disease.
Our Partners
Invest in Our Vision
Our investors share our unwavering passion for our work, and we welcome further investments to support our mission.
Latest Developments
Expanding Presence in the USA by 2025.
Explore Career Opportunities
Are you a student or recent graduate in the fields of genomics and bioinformatics seeking a summer internship? Your search ends here! Genevation LTD is actively seeking motivated individuals to join our team and gain hands-on experience in the field. Apply now and embark on a rewarding career in genomics and bioinformatics.
Connect with Us
Discover us at Stevenage Bioscience Catalyst,
Gunnels Wood Rd, Stevenage SG1 2FX
Get in Touch
Visit us at Stevenage Bioscience Catalyst,
Gunnels Wood Rd, Stevenage SG1 2FX
Email: prasun.chakraborty@genevation.co.uk
Contact: 00447982983251
USA Contact
BioLabs San Diego
9276 Scranton Road Suite 500
San Diego, CA 92121